regulation

News

UK okays early access to Gilead's remdesivir in seriously il...

The UK’s drugs regulator has said that there is enough evidence to support the use of Gilead’s COVID-19 drug remdesivir under its Early Access to Medicines Scheme (EAMS).

News

Japan approves Gilead's COVID-19 drug remdesivir

Japan’s regulator has quickly approved Gilead’s remdesivir for patients with severe COVID-19, after the FDA allowed its use as an emergency treatment for the disease earlier this month.

News

hydroxychloroquine sulphate tablets, in evaluation for treatment of COVID-19.Denmark, Mars 22, 2020

EU regulators warn over safety of Trump's favourite COVID dr...

As the search for therapies for COVID-19 continues, European regulators have urged caution over the cardiac side-effects of chloroquine and its close relative hydroxychloroquine.

News

FDA hastens development of Novartis' Kymriah in follicular l...

Novartis will receive extra help from the FDA during the development of its CAR-T cancer cell therapy Kymriah for follicular lymphoma, after the regulator deemed it to be an advanced regene

News

FDA backs first COVID-19 test with home collection option

The FDA has backed the first COVID-19 diagnostic with a home collection option, at a time when the US is struggling to keep pace with the pandemic and suffering from a shortage of tests.

News